Risk Management for Patients Receiving Ticlopidine Hydrochloride and Its Evaluation-Proper Use of Ticlopidine in Patients After Percutaneous Coronary Intervention (PCI)-
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
doi 10.5649/jjphcs.31.986
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2005
Authors
Publisher
Japanese Society of Pharmaceutical Health Care and Sciences